All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • Special reports
    • Artificial intelligence
    • Coronavirus
  • Market intelligence reports
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, February 6, 2020
Home » Cell therapy firm Agex looks west to expand into Japan
Looking to read the full article? Subscribe to BioWorld.
Newco news

Cell therapy firm Agex looks west to expand into Japan

January 29, 2020
By Lee Landenberger
No Comments
In its first step into Japan, Agex Therapeutics Inc. accelerates its development of engineering hypoimmunogenic cells, universal cells that can be used on patients who didn’t generate the original cell and without the need to use immunosuppressants.
BioWorld Cell therapy Newco news

Already a subscriber? Sign in 

Popular Stories

  • Coronavirus-vaccine-patient

    Gilead’s remdesivir enters China phase III trial to fight coronavirus

    BioWorld
    BEIJING – China will kickstart a phase III trial Feb. 3 to determine whether patients with 2019-nCoV can be treated with Gilead Sciences Inc.’s NUC inhibitor,...
  • Traditional-chinese-medicine3

    Coronavirus: Chinese researchers claim TCM herbal remedy could ‘inhibit’ 2019-nCoV

    BioWorld
    HONG KONG – In another example that communication is proving as difficult as containment in the current coronavirus outbreak, China’s state media reported, to...
  • 1-22-founder-fund-thiel

    Thiel calls for improving research grant, regulatory processes to enhance scientific innovation

    BioWorld
    SANTA CLARA, Calif. – Peter Thiel is not a fan of incremental science. The high-profile venture capital investor, who invests across technology and the life...
  • Coronavirus-test-tube

    Hong Kong researchers develop coronavirus vaccine

    BioWorld

    HONG KONG – As drug developers are racing to find a cure for the new coronavirus, researchers in Hong Kong claim to have made major headway in the development of...

  • 1-15-insulet-omnipod-dash

    Insulet to launch wearable insulin pump this year, works with Dexcom iCGM for closed loop

    BioWorld MedTech
    SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod...
cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Archives
    • Contact us
    • Cookie policy
    • Copyright notice
    • Privacy policy
    • Share your news
    • Staff
    • Terms of use
Follow Us

Copyright ©2020. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing